The Pulmonary Hypertension Association (PHA), the country’s lead non-profit organization for pulmonary hypertension (PH), has just…
PatrĂcia Silva, PhD
PatrĂcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĂcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by PatrĂcia Silva, PhD
United Therapeutics Corporation has signed an agreement with DEKA Research & Development Corp., to continue the development of a…
As the year 2014 comes to a close, Pulmonary Hypertension News – your reliable online source for the latest…
Biopharmaceutical company and leader in pulmonary arterial hypertension (PAH) therapeutics, Actelion Ltd., has…
United Therapeutics Corporation recently announced that Medtronic, Inc., the world’s third largest medical device company, has forwarded a pre-market approval application to the …
The Pulmonary Hypertension Association, one of the country’s most prominent non-profit support, education, advocacy and awareness associations, has just…
Specialized care for those with Pulmonary Hypertension continues to improve across America, with an increasing number of physicians and…
Late-stage cell therapy company Cytori Therapeutics, Inc. will host an informational session about its pivotal STAR clinical trial,…
Popular online shopping destination eBay, through its subsidiary, eBay, Inc. Foundation, recently awarded the Pulmonary Hypertension Association (PHA) a grant worth $3,000…
Findings from a study entitled “Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary…
GlaxoSmithKline (GSK) recently announced it has applied for a European Medicines Agency (EMA) variation to the Marketing Authorization for ambrisentan…
Silence Therapeutics recently developed a genetic toolkit to support the company’s research into to several diseases, including pulmonary…